Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 7/7/2020
SIETES contiene 93061 citas

 
 
 1 a 5 de 5 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, ten Berg JM, Steg PG, Hohnloser SH, for the RE-DUAL PCI Steering Committee and Investigators. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2017;377:1513-24. [Ref.ID 102099]
2.Tiene citas relacionadas
Dewilde WJM, Verheugt FWA, ten Berg JM. Antiplatelet therapy and anticoagulants - Authors' reply. Lancet 2013;382:25. [Ref.ID 95787]
3.Tiene citas relacionadas Cita con resumen
Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herman J-P, Adriaenssens T, Vrolix M, Heestermans AA, Vis MM, Tijsen JG, van't Hof AW, ten Berg JM, for the WOEST study investigators. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 2013;381:1107-15. [Ref.ID 95174]
4.Tiene citas relacionadas Cita con resumen
Bauer T, Bouman HJ, van Werkum JW, Ford NF, ten Berg JM, Taubert D. Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis . BMJ 2011;343:353. [Ref.ID 91193]
5.Tiene citas relacionadas
Kastrati A, Mehilli J, Schühlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann F-J, Bollwein H, Volmer C, Gawaz M, Berger PB, Schömig A, for the Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment (ISAR-REACT) Study Investigators. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004;350:232-8. [Ref.ID 68730]
Seleccionar todas
 
 1 a 5 de 5